![Philippe Ledent](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Mr. Philippe Ledent is a Chief Scientific Officer & Director at Xpress Biologics SA and a Senior Economist at ING Belgium SA/NV.
He is on the Board of Directors at Xpress Biologics SA. He’s responsible for economic scenario and structural research on Belgium and Luxembourg.
Previously, he worked at the Catholic University of Louvain.
Posizioni attive di Philippe Ledent
Società | Posizione | Inizio |
---|---|---|
ING Belgium SA/NV
![]() ING Belgium SA/NV Investment Banks/BrokersFinance ING Belgium SA/NV is the wholly owned securities broker/dealer subsidiary of ING Groep NV (AMS: INGA) in The Netherlands. Headquartered in Brussels, the firm provides brokerage services to various investors. | Economista | 01/01/2008 |
Xpress Biologics SA
![]() Xpress Biologics SA BiotechnologyHealth Technology Xpress Biologics SA develops and produces bio molecules for medical applications. It engages in design of expression systems, process development and manufacturing of new biologics, biosimilars and biobetters, management of the pre-clinical and clinical trials and management of the GMP manufacturing services. The company was founded by Marc Daukandt, Philippe Ledent and Christian Rodriguez on April 14, 2014 and is headquartered in Milmort, Belgium. | Fondatore | 14/04/2014 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
ING Belgium SA/NV
![]() ING Belgium SA/NV Investment Banks/BrokersFinance ING Belgium SA/NV is the wholly owned securities broker/dealer subsidiary of ING Groep NV (AMS: INGA) in The Netherlands. Headquartered in Brussels, the firm provides brokerage services to various investors. | Finance |
Xpress Biologics SA
![]() Xpress Biologics SA BiotechnologyHealth Technology Xpress Biologics SA develops and produces bio molecules for medical applications. It engages in design of expression systems, process development and manufacturing of new biologics, biosimilars and biobetters, management of the pre-clinical and clinical trials and management of the GMP manufacturing services. The company was founded by Marc Daukandt, Philippe Ledent and Christian Rodriguez on April 14, 2014 and is headquartered in Milmort, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Philippe Ledent